By AuntMinnie.com staff writers

November 19, 2010 -- Contrast injector technology firm Medrad of Warrendale, PA, plans to highlight its personalized-protocol software that individualizes CT pulmonary angiography (CTPA) contrast dosing at the upcoming RSNA meeting.

The company's P3T PA (pulmonary angiography) software allows for improved diagnostic-quality studies by fitting into a facility's established CTPA workflow and making consistent administration of personalized contrast dosing practical, according to Medrad.

The software's algorithm tailors each patient's contrast protocol based on technologists' touchscreen responses to particular clinical concerns, study requirements, and the scanning equipment used, Medrad said.

Medrad signs Novation deal, August 23, 2010

Medrad signs distribution pact, August 3, 2010

Medrad gets FDA OK for Intego, July 7, 2010

Medrad inks PET deal with MGH, June 7, 2010

Medrad, Pinestar team up, May 19, 2010

Copyright © 2010 AuntMinnie.com

 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: